EnCore downgraded to Speculative Buy from Buy at Cantor Fitzgerald
Cantor Fitzgerald downgraded EnCore Energy (EU) to to Speculative Buy from Buy with a C$7.25 price target Discover the Best Stocks and ...
Surgery Partners outlines 2025 guidance with $3.3B-$3.45B revenue target, driven by high acuity growth
Discover key takeaways from Surgery Partners' Q4 2024 earnings call, including strong revenue growth, strategic M&A, and 2025 guidance with robust ...
Cantor Fitzgerald and Silverstein Properties Close Opportunity Zone Fund with more than $470 Million of Capital Raised
Cantor Fitzgerald, L.P. ("Cantor"), a leading global financial services firm, and Silverstein Properties, Inc. ("Silverstein"), a leading global full-service real estate development, investment, and ...
Esperion Therapeutics (ESPR) Projected to Post Quarterly Earnings on Tuesday
Esperion Therapeutics (NASDAQ:ESPR – Get Free Report) is expected to issue its quarterly earnings data before the market opens on Tuesday, March 4th. Analysts expect the company to announce earnings ...